# A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD

> **NCT03831607** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 67 (actual)

## Conditions studied

- Hyperphosphatemia

## Interventions

- **DRUG:** KHK7791

## Key facts

- **NCT ID:** NCT03831607
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-27
- **Primary completion:** 2019-11-26
- **Final completion:** 2019-11-26
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03831607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03831607, "A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03831607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*